Allogene Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Allogene Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $688k | 609k | 1.13 |
| 2024-12-31 | $2.1M | 999k | 2.13 |
| 2024-09-30 | $4.8M | 1.7M | 2.80 |
| 2024-06-30 | $5.0M | 2.2M | 2.33 |
| 2024-03-31 | $10M | 2.2M | 4.47 |
| 2023-12-31 | $5.4M | 1.7M | 3.21 |
| 2023-09-30 | $4.4M | 1.4M | 3.17 |
| 2023-06-30 | $6.6M | 1.3M | 4.97 |
| 2022-12-31 | $5.3M | 851k | 6.29 |
| 2022-06-30 | $12M | 1.1M | 10.36 |
| 2022-03-31 | $0 | 1.7M | 0.00 |
| 2021-06-30 | $29M | 1.1M | 26.04 |
| 2020-12-31 | $0 | 343k | 0.00 |
| 2020-09-30 | $0 | 200k | 0.00 |
| 2020-06-30 | $0 | 47k | 0.00 |
| 2020-03-31 | $919k | 47k | 19.42 |
| 2019-12-31 | $2.1M | 80k | 25.98 |
| 2019-09-30 | $864k | 32k | 27.28 |
| 2019-03-31 | $260k | 9.0k | 28.86 |
| 2018-12-31 | $990k | 37k | 26.94 |